Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Calcitonin for postmenopausal bone loss

J W Studd, R J Baber

    Lancet (London, England)
    |June 4, 1988
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Using menopausal hormone therapy to prevent fracture recurrence in older women: is it time to change our opinion?

    Climacteric : the journal of the International Menopause Society·2021
    Same author

    The effects of phytoestrogens on postmenopausal health.

    Climacteric : the journal of the International Menopause Society·2021
    Same author

    A brief history of the International Menopause Society.

    Climacteric : the journal of the International Menopause Society·2017
    Same author

    Cardiovascular risk assessment in women - an update.

    Climacteric : the journal of the International Menopause Society·2016
    Same author

    2016 IMS Recommendations on women's midlife health and menopause hormone therapy.

    Climacteric : the journal of the International Menopause Society·2016
    Same author

    Prevention of diseases after menopause.

    Climacteric : the journal of the International Menopause Society·2014
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    Same journal

    Dual mobility total hip replacement in fractures: stability promotes patient confidence.

    Lancet (London, England)·2026
    Same journal

    Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

    Lancet (London, England)·2026
    See all related articles